PEDIATRIC PUZZLER: Persistent fever in a 6-year-old: Licking the diagnosis

Article

The call at 3 a.m. on a warm May morning is from the emergency department. The ED physician is seeing a 6-year-old with a seven- to 10-day history of fever as high as 105? F, swollen glands, lethargy, and poor oral intake.

Newsletter

Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.

Subscribe Now!
Recent Videos
Contemporary Pediatrics: RX Review: Updates and Unmet Need in RSV thumbnail
Contemporary Pediatrics: RX Review: Updates and Unmet Need in RSV thumbnail
Contemporary Pediatrics: RX Review: Updates and Unmet Need in RSV thumbnail
Staphylococcus aureus risk in infants and neonatologist considerations with Aaron Milstone, MD
How fragrance plays a role in atopic dermatitis treatments, with John Browning, MD
Octavio Ramilo, MD, reacts to the FDA approval of clesrovimab for RSV prevention | Image Credit: St. Jude Children's Research Hospital
Related Content
AAP updates guidance on genetic testing for developmental delay | Image Credit: © Cavan - stock.adobe.com.

AAP updates guidance on genetic testing for developmental delay

Morgan Ebert, Managing Editor
June 23rd 2025
Article

AAP updates clinical guidance to help pediatricians navigate genetic evaluation of children with global developmental delay or intellectual disability.

Site Logo

Food Insecurity and the Dangers of Infant Formula Dilution

January 30th 2023
Podcast
Prenatal exposure to PFAS linked to higher adolescent blood pressure in diverse birth cohort | Image Credit: © Francesco Scatena - stock.adobe.com.

Prenatal exposure to PFAS associated with higher blood pressure in adolescence

Morgan Ebert, Managing Editor
June 23rd 2025
Article

Prenatal PFAS exposure was linked to higher adolescent blood pressure according to a recent study.

Demystifying Infant Formula

Demystifying Infant Formula

October 11th 2022
Podcast
FDA extends review of ruxolitinib cream for pediatric atopic dermatitis | Image credit: Contemporary Pediatrics.

FDA extends review of ruxolitinib cream for pediatric atopic dermatitis

Morgan Ebert, Managing Editor
June 20th 2025
Article

The FDA has extended the review of ruxolitinib for atopic dermatitis in children 2 to 11 years to September 2025 to evaluate new CMC data.

John Browning, MD, provides practical skincare reminders ahead of summer season

John Browning, MD, provides practical skincare reminders ahead of summer season

John Browning, MD
June 20th 2025
Article

Pediatric dermatologist John Browning, MD, offers practical sun safety tips and guidance for selecting sunscreens, emphasizing the importance of choosing formulations that work for sensitive skin.

© 2025 MJH Life Sciences

All rights reserved.